ventricular hypertrophy evaluated as a change in organ weight, aggregate myocyte mass, and myocyte cell volume per nucleus showed increases of 85%, 47%, and 103%, respectively. Corresponding increases in the right ventricle were 75%, 74%, and 112%. Myocyte loss, which accounted for 28% and 30% in the left and right ventricles, was responsible for the difference in the assessment of myocyte hypertrophy at the ventricular, tissue, and cellular levels. Left ventricular muscle cell hyper-I schemic cardiomyopathy is an anatomic condition initiated by primary events in the coronary circulation that lead to myocyte loss, scarring, and ventricular failure. Cell loss occurs as a result of narrowing and/or occlusion of coronary arteries by atherosclerosis, spasm of major or intramural arterial branches of the coronary vasculature, or alterations of the microcirculation, which, alone or in combination, produce varying degrees of ischemia and tissue injury.1-6 The clinical spectrum ranges from acute myocardial infarction to chronic ischemic cardiomyopathy. The latter case may take the form of a dilated ischemic myopathy characterized by multiple focal sites of myocardial damage in the ventricular wall.7 In the most common manifestation, in which scattered foci of replacement fibrosis are found in conjunction with a healed infarct, the question remains concerning the pathophysiological significance of these two types of myocardial lesions. Specifically, it has not been established whether the segmental loss of myocar-trophy was accomplished through a 16% and 51% increase in myocyte diameter and length, whereas right ventricular myocyte hypertrophy was the consequence of a 13% and 67% increase in these linear dimensions, respectively. Moreover, a 36% reduction in the number of myocytes included in the thickness of the left ventricular wall was found. Collagen accumulation in the form of segmental, replacement, and interstitial fibrosis comprised an average 28% and 13% of the left and right ventricular myocardia, respectively. The combination of cell loss and myocardial fibrosis, myocyte lengthening, and mural slippage of cells resulted in 4.6-fold expansion of left ventricular cavitary volume and a 56% reduction in the ventricular mass-to-chamber volume ratio.
Conclusions These results are consistent with the contention that both myocyte and collagen compartments participate in the development of decompensated eccentric ventricular hypertrophy in the cardiomyopathic heart of ischemic origin. (Circulation. 1994; 89:151-163.) Key Words * hypertrophy * collagen * dilation dium associated with coronary artery occlusion and infarction is the principal determinant of myocyte cell loss, wall thinning, ventricular dilation, and worsening of the hemodynamic performance with time or whether the multiple isolated sites of tissue injury in the noninfarcted portions of the wall are major factors in the progression of the cardiac myopathy. In addition, both forms of ischemic damage reduce the amount of functioning myocardium, increasing the load on the surviving region of the ventricle, which undergoes compensatory reactive hypertrophy. [6] [7] [8] [9] This growth process may expand the length of the unaffected myocytes more than myocyte diameter, contributing to chamber dilation and relative thinning of the wall.10,11 Ventricular dilation has repeatedly been demonstrated to constitute an unfavorable outcome of the ischemic cardiomyopathic heart acutely and chronically. [12] [13] [14] [15] [16] Moreover, this anatomic factor has been shown to limit survival in both humans and animal models.9 Therefore, the present investigation was undertaken to analyze the quantitative structural properties of hearts removed from patients undergoing cardiac transplantation as a result of chronic ischemic heart disease and refractory congestive heart failure. Hearts collected at autopsy from individuals who died from causes other than cardiovascular disease were used as controls.
Medical School from June 1989 to May 1992. These patients had a history of myocardial infarction and severe coronary artery disease. Intractable congestive heart failure was the cause of cardiac transplantation. An additional group of 10 hearts was collected at autopsy, within 24 hours after death, and assumed to represent normal hearts. According to preautopsy criteria, autopsy criteria, and histological criteria that have been described in detail previously,17 these hearts were used as controls. In 7 of the 10 patients whose hearts were used as controls, death was sudden and provoked by a traumatic injury. In the remaining 3 cases, cerebral hemorrhage was found in 2 and pulmonary thromboembolism in 1. In these 3 patients, death occurred within 5 days after hospitalization.
Cardiac Weight
After excision of the heart, the great vessels were removed, the atria were dissected free along the atrial ventricular groove, and the coronary arteries were cut perpendicularly to their course for the assessment of the degree of atherosclerosis. The epicardial fat was then carefully removed, the valves were cut free, and the weights of the left ventricle inclusive of the septum and right ventricular free wall were determined. Ventricular mass volume was then computed by dividing ventricular weight by the specific gravity of muscle tissue, 1.06 g/mL.U8 Before sectioning, the major longitudinal intracavitary axis of the left ventricle was determined. 19 
Preparation of Myocardial Specimens
The two ventricles of each heart were sliced into seven sections, approximately 15 mm in thickness, perpendicularly to the major axis of the heart from the apex to the base. These sections were then examined grossly for the assessment of large areas of myocardial fibrosis. The midsection (No. 4) was used to estimate transverse chamber diameter and wall thickness.'7 Subsequently, the two middle slices of the free wall of each ventricle (sections 4 and 5) were cut radially to obtain tissue fragments extending from the endocardial to the epicardial surface. These samples were fixed in 10% buffered formalin and embedded in paraffin. An additional sampling of two tissue blocks from each remaining slice of each ventricle and two from the interventricular septum was obtained and embedded in paraffin for further estimation of the presence of myocardial fibrosis and tissue injury.
Tissue Sampling for the Estimation of Replacement Fibrosis
Quantitative analysis was restricted to the two transverse myocardial slices of both ventricles, which were completely processed for histological examination. These multiple samples were sectioned and stained with hematoxylin and eosin and trichrome. Subsequently, each stained histological section was examined with a microscope equipped with a camera connected to a computerized image-analysis system (IBAS; Zeiss, Oberkochen, Germany). For the evaluation of the volume percent of the myocardium occupied by foci of replacement fibrosis, all sections obtained from the two transverse myocardial slices of each ventricle were evaluated with a x2.5 objective that defined a final tissue area of 4.4 mm2. By this approach, the areas of tissue occupied by these discrete myocardial lesions and normal myocardium were determined to compute their relative volumes in each ventricle. 20 Tissue Sampling for the Estimation of Myocyte Nuclear Numerical Density and Myocyte Nuclear Length Six randomly chosen embedded tissue blocks from each ventricle were sectioned at a thickness of 2 to 3 ,um and stained with hematoxylin and eosin. These sections were examined with a x63 objective, which defined a tissue area of 9911 gum2.
Morphometric sampling consisted of counting the total number of myocyte nuclear profiles, N(n), in a measured area, A, of tissue sections in which cardiac muscle fibers were sectioned transversely. A square tissue area was delineated in the projected field by a grid containing 42 sampling points. One hundred fields were evaluated in each ventricle of each heart to determine the mean number of nuclear profiles per unit area of myocytes, N(n)A. Average nuclear length, DI, was determined from 50 measurements in each ventricle, which were made at a magnification of x630 in longitudinally oriented myocytes. Only those nuclei in which the nuclear envelope was sharply defined at both ends and in which clusters of mitochondria were clearly visible in the areas adjacent to the nuclear edges were measured. 21 In addition, myocyte diameter, d, in the region of the nucleus was obtained in these cells.
Tissue Sampling for Estimation of Volume Composition of Myocardium
The same tissue blocks used for the evaluation of nuclear numerical density and length were used here. However, sections were stained with trichrome, and their projected images were examined with the morphometric grid indicated above. In particular, the volume percent of myocytes in the tissue, V(m)v, was obtained by counting the fraction of points overlying the myocyte compartment in each of the 100 fields examined.20 Similarly, the volume fraction of the nonmyocyte compartment occupied by interstitial fibrosis and vascular framework was estimated from the number of points lying over these two tissue components.
Morphometric Calculations
The data of myocyte nuclear numerical density, N(n)A, nuclear length, Dn, and volume fraction of myocytes in the myocardium were combined to yield the average measurement of the number of myocyte nuclei per unit volume of myocytes, N(n)v, in the ventricle using the following equation20'21: 
Statistical Analysis
All morphometric data were collected blindly, and the code was broken at the end of the experiment. Results are presented as mean+SD computed from the average measurements obtained from each heart. Statistical significance for comparison between two measurements was determined using the unpaired two-tailed Student's t test. Values of P<.05 were considered to be significant. 
Results

Clinical Data
The 10 patients affected by ischemic cardiomyopathy had New York Heart Association functional class III or IV. The duration of heart failure was 23±24 months (range, 5 to 84 months). Ejection fraction was 22±8%. Diabetes and pulmonary hypertension singularly or in combination were found in 4 of the 10 patients. Chronic obstructive pulmonary disease and thalassemia minor were seen in 2 of these 4 cases. None of the patients had a history of systemic hypertension, but all suffered from a previous myocardial infarction. The initial myocardial infarction was as remote as 14 years and as recent as 8 months before transplantation, averaging 6±4 years in the entire group. Six patients previously had received single or multiple coronary bypass surgery. Left ventricular aneurysm was found in 4 patients.
Control hearts were obtained from individuals similar in age, body weight, body surface, and height (Table 1) who died not as a result of primary heart disease or as a consequence of major risk factors of coronary artery disease, including hypertension, diabetes, obesity, and/or severe atherosclerosis. In addition, the autopsy report and the histological examination of all organs excluded diffuse, metastatic malignant neoplasms and chronic inflammatory states. In three of the seven patients in whom death was associated with a traumatic injury (see "Methods"), a complete medical history could not be obtained. Their suitability as controls was based on the absence of a previous hospital record and on the fact that the autopsy failed to reveal underlying pathological processes, with the exception of the damage produced by the acute traumatic injury. A detailed description of the multiple criteria used to characterize a normal individual and a nonpathological heart has recently been provided. 17 Anatomic Parameters Table 1 shows the age of the patients and the gross characteristics of the left and right ventricles after careful dissection of the epicardial fat. Ischemic heart disease was associated with an 85% and 75% increase in left and right ventricular weight, respectively. When cardiac weights were normalized by body weight, left and right ventricular weight-to-body weight ratio increased by 2.0-fold and 1.9-fold, respectively. Similar changes were seen with regard to body surface. The thickness of the anterior, lateral, and posterior aspects of the left ventricular wall was comparable in normal and diseased hearts, whereas average right ventricular wall thickness increased 36% with ischemic cardiomyopathy. ber volume ratio in the absence of an increase in the average thickness of the wall (Table 1) .
In view of the difficulty in the determination of right ventricular chamber volume, right ventricular wall area was calculated as previously performed. 23 The computation of ventricular wall area, which is obtained by dividing wall volume by wall thickness,23 assumes that the ventricular wall may be treated as a thin sheet. Thus, increases in wall area imply larger chamber volumes. By this approach, it was found that this parameter was 109±+18 cm2 in normal hearts and 149+46 cm2 in ischemic cardiomyopathy. The 37% difference was found to be statistically significant (P<.05). However, such an expansion in wall area was significantly less than the magnitude of hypertrophic growth in the right ventricular wall (Table 1) .
In summary, ischemic cardiomyopathy led to cardiac hypertrophy and ventricular dilation. However, the expansion in chamber volume exceeded the growth response of the myocardium in the left ventricle, whereas an opposite effect was found in the right ventricle. Myocardial Structure Gross sectioning of the coronary vasculature revealed severe diffuse coronary atherosclerosis involving the three major vessels in all cases. Occlusions of one or two coronary arteries were found in each of the 10 cases. Although histological examination did not show thickening of the wall or other pathological changes of the intramural branches of the coronary arterial tree, the impossibility of fixing the myocardium by perfusion of the coronary vasculature limited the light microscopic analysis of intermediate-sized arteries and arterioles. Thus, an accurate study of the intramyocardial coronary artery branches could not be performed.
Segmental fibrosis, replacement fibrosis, and interstitial fibrosis are used as quantitive definitions. In this investigation, segmental fibrosis defines a healed myocardial infarct that comprises an area of myocardium > 1 cm2, whereas replacement fibrosis describes discrete areas of myocardial scarring developed as a result of focal myoeyte cell loss. These sites of myocardial injury vary in size but are <1 cm2. Finally, interstitial fibrosis corresponds to widening of the interstitial space with collagen accumulation in the absence of apparent myocytolytic necrosis and focal cell death. These three forms of tissue injury have been described previously (for review, see Reference 7) to distinguish the effects of occlusion of a major coronary artery from those involving small branches of the coronary circulation or activation of interstitial fibroblasts, independent of myocyte cell death. Figs 2A, 2B, 3A, and 3B illustrate these different aspects of myocardial damage.
Gross inspection of the slices of the left ventricle inclusive of the interventricular septum and right ventricle of each heart revealed segmental areas of myocardial (Fig 3A) . Furthermore, the myocardial tissue, free of these foci of damage, showed diffuse interstitial fibrosis (Fig 3B) that involved the wall of the left and right ventricles. larger site of replacement fibrosis was 30x 106 tm2 and the third was 25 x 106 um2, both ofwhich were seen as isolated examples in two separate cases. Thus, the quantification of replacement fibrosis included foci < 1 cm2. This dimension was assumed to represent the upper limit for this form of myocardial damage. Such an arbitrary approach implied that areas of myocardial scarring >1 cm2 had to be considered as microinfarcts. Fig 4C shows the volume fraction of replacement and interstitial fibrosis in the right ventricular myocardium. Ischemic cardiomyopathy resulted in 4.0-fold (P<.001) and 2.8-fold (P<.0001) increases in these two forms of myocardial scarring, which together were found to comprise an average 13% of the ventricular wall. Moreover, the mural distribution of replacement fibrosis (Fig 4D) was similar to that seen in the left ventricle (Fig 4B) , because this tissue parameter occupied a larger fraction of the endomyocardium than of the epimyocardium. However, similar increases in the relative volume of replacement fibrosis in the endomyocardium (3.7-fold; P<.005) and epimyocardium (4.5-fold; P<.0001) were detected with ischemic cardiomyopathy.
In summary, ischemic cardiomyopathy was characterized by segmental myocardial scarring, replacement fibrosis, and interstitial fibrosis that markedly altered the normal structure of the myocardium.
Number of Myocyte Nuclei in the Ventricles
The primary measurements that were used for derivation of the numerical density of myocyte nuclei per unit volume of myocytes consisted of the determination of the number of myocyte nuclei per unit area of myocytes and the evaluation of average nuclear length. The products of these parameters with the aggregate volume of myocytes in the ventricular myocardium yielded the total number of myocyte nuclei in the ventricles. 21 The results obtained in normal and diseased hearts are shown in Fig 5. In comparison with control hearts, the left ventricle of cardiomyopathic hearts showed a 28% (P<.01) loss in the total number of myocyte nuclei. This measurement included the contribution of myocardial infarction. A 30% (P<.05) loss in myocyte nuclei was found in the right ventricle. It should be noted that these decreases in the total number of myocyte nuclei in the ventricles correspond to identical changes in myocyte number if the proportion between mononucleated and binucleated cells in the myocardium remains essentially constant.
In summary, ischemic cardiomyopathy led to a significant amount of myocyte loss in the ventricular myocardium. ceeded the increase in left ventricular mass, which, in turn, exceeded the expansion in total myocyte volume.
Figs 7C and 7D illustrate how ischemic cardiomyopathy affected the absolute amounts of myocytes and collagen in the right ventricular wall. The myocyte compartment was seen to be increased by 74% (P<.01). In addition, the magnitude of replacement and interstitial fibrosis increased 6.9-fold (P<.0001) and 4.6-fold (P<.0001). As a whole, connective tissue increased 5.3-fold (P<.0001). Thus, the accumulation of collagen in the right ventricular myocardium was greater than the overall increase in right ventricular and myocyte mass. Table 2 lists the relative and absolute amounts of segmental, replacement, and interstitial fibrosis in the left and right ventricular myocardia of each cardiomyopathic heart. In 6 of the 10 cases, the magnitude of replacement fibrosis in the left ventricle exceeded the extent of scarring associated with myocardial infarction. In 3 instances, segmental fibrosis involved a larger portion of the left ventricle than replacement fibrosis, whereas both forms of scarring were essentially identical in the 1 remaining case. In 8 cases, replacement and interstitial fibrosis combined represented the major source of collagen accumulation in the left ventricle. Finally, the analysis of the seven slices of each left ventricle (see "Methods") demonstrated that a single myocardial infarct was found in eight cases and two infarcts in two cases (hearts 5 and 6 in Table 2 ). These were healed infarcts and no acute lesions were noted.
In patient 5 (Table 1) , there was an infarct comprising 8% of the anterolateral aspect of the left ventricular free wall and a second infarct involving 5% of the posterior portion of the left ventricle. These areas of segmental fibrosis were associated with severe atherosclerosis and marked reductions in luminal diameter of the left anterior descending and left and right circumflex coronary arteries. Patient 6 ( Table 1) had two infarcts affecting 10% and 7% of the interventricular septum and posterior region of the left ventricular wall, respectively. Coronary atherosclerosis with severe narrowing of all major epicardial coronary arteries was present. In the remaining eight cases, the size of each infarct is listed first in Table 2 as segmental fibrosis. It should be emphasized that foci of myocardial scarring <1 cm2 were not included in this category.
In the right ventricle, segmental fibrosis was absent in all cases, and replacement fibrosis was the predominant form of collagen accumulation in six hearts. Interstitial fibrosis exceeded replacement fibrosis in three instances, whereas similar values in these two aspects of myocardial damage were seen in one case. In comparison with the left ventricle, the volume percent of replacement fibrosis in the corresponding right ventricle was significantly less in 9 of the 10 cardiomyopathic hearts. The relative amount of interstitial fibrosis was more variable in the 2 ventricles. This parameter was higher in the left ventricle in 4 cases, less in 4, and similar in 2. However, in 9 hearts, the volume fraction of replacement and interstitial fibrosis combined was lower in the right ventricle than in the left ventricle.
In summary, ischemic cardiomyopathy was characterized by accumulation of collagen biventricularly, mostly in the form of replacement and interstitial fibrosis. 
Discussion
The results of the present study indicate that ischemic cardiomyopathy in its terminal stage was characterized by decompensated eccentric left ventricular hypertrophy, documented by an increase in cardiac weight and a decrease in the ventricular mass-to-chamber volume ratio. Myocardial damage consisted of healed infarcts, multiple foci of replacement fibrosis across the ventricular wall, and diffuse interstitial fibrosis. These different forms of tissue injury were associated with a significant amount of myocyte loss and reactive hypertrophy of the remaining viable cells. The growth response of myocytes, however, showed an increase in cell length that exceeded the lateral expansion of the cell. Such a change in myocyte shape contributed to ventricular dilation and relative thinning of the wall. Importantly, the addition of myocyte muscle mass by cellular hypertrophy was less than that of collagen, so diffuse myocardial fibrosis and myocyte cell loss may represent the major structural rearrangements of the failing cardiomyopathic heart of ischemic origin. Ischemic Cardiomyopathy and Ventricular Hypertrophy
Increasing pressure loading on the heart induces concentric ventricular hypertrophy in which wall thickness increases without chamber enlargement.10,1124 In its compensated form, mural thickening is the result of an increase in myocyte diameter with no change in the mural number of myocytes or in the aggregate number of cells in the entire ventricle. 24 The combination of these events leads to an augmentation in the ventricular mass-to-chamber volume ratio.10,1" On the other hand, an increased volume load typically results in eccentric ventricular hypertrophy in which chamber volume enlarges without a relative increase in wall thickness. 10, 11, 24 In its compensated stage, chamber dilation is produced by myocyte lengthening, whereas the ventricular number of cells is not altered.24 Importantly, myocyte diameter also increases, so that a modest absolute increase in wall thickness occurs and the ratio of wall thicknessto-chamber radius remains constant.24 In addition, the proportion between ventricular mass and chamber volume does not vary. When these relations are not preserved, decompensated concentric and eccentric hypertrophy develop,10,11,24 as shown here in the form of ischemic cardiomyopathy. Specifically, the longitudinal and transverse left ventricular cavitary diameters increased 15% and 99%, respectively, provoking a 4.6-fold expansion in chamber volume. Mural thickening was not observed, and reactive hypertrophy nearly doubled the magnitude of ventricular mass inclusive of the nonmyocyte components of the myocardium. These anatomical rearrangements resulted in a marked decrease in the ratios of wall thickness-to-chamber radius and ventricular mass-to-chamber volume. Thus, eccentric left ventricular hypertrophy in its decompensated form characterized congestive heart failure of ischemic origin.
More complex is the description of the phenomena involved in the adaptation of the right ventricle in ischemic cardiomyopathy. Results showed a modest 37% expansion in wall area coupled with a 75% increase in ventricular mass. These data are consistent with an increase in ventricular mass-to-chamber volume ratio and a concentric hypertrophic response.10'11 However, the greater wall area implies that chamber dilation occurred under these conditions, demonstrating that anatomic indexes of cardiac decompensation were present on this side of the heart as well.
Ventricular dilation and relative wall thinning have been shown to be consistent determinants of the acute and chronic adaptations of the ventricular myocardium following ischemic injury in both humans and animal models.9'12 '16,19,25 These alterations in ventricular size and shape occur as a result of a segmental loss of muscle mass due to infarction12-14 or as a consequence of scattered foci of tissue damage across the ventricular wall associated with severe degrees of coronary artery constriction.26,27 Both situations encountered here most likely represent the primary factors responsible for the sequence of events that led to the increase in ventricular cavitary volume and congestive heart failure.
Two structural mechanisms recently have been identified in the genesis of ventricular dilation in ischemic cardiomyopathy. The first one involves an architectural rearrangement of the myocyte compartment with sideto-side slippage of cells within the wall and mural thinning,15'28 whereas the second one concerns the pattern of the myocyte hypertrophic reaction in which the increase in cell length significantly exceeds the lateral growth of myocytes.29 '30 Muscle fiber slippage appears to be an early adaptive response of the wall to the elevated diastolic ventricular pressure28'31-33 and may account for most of the acute expansions in cavitary volume associated with regional15'28 and global7'31-33 ischemia. However, myocyte lengthening is a chronic phenomenon that can be expected to generate a larger chamber size without affecting wall thickness.21 '29'30 Myocyte cell slippage has also been implicated in the adaptive response of the heart to pressure34 and volume35 overloads. In the present study, a 36% decrease in the number of myocytes included in the thickness of the left ventricular wall was found in combination with biventricular myocyte hypertrophy. In this regard, the increases in left and right ventricular myocyte length were 51% and 67%, whereas the corresponding increases in myocyte diameter were only 16% and 13%, respectively. Thus, these observations suggest that chronic myocardial ischemia is coupled with changes in the mural number of myocytes, consistent with side-toside movement of cells within the wall, and myocyte lengthening. These anatomic variables contributed to ventricular dilation and the development of decompensated eccentric left associated with pathological states of the heart. This approach repeatedly has been considered to provide a reliable index of the degree of reactive growth occurring at the level of myocytes. However, this type of analysis is valid only under the conditions in which the proportion among the different structural constituents of the myocardium is not altered and the number of cells in the ventricle remains constant.36 This is not the case after coronary occlusion and myocardial infarction or after coronary constriction and focal tissue damage. Chronic myocardial ischemia was found here to expand total myocyte mass in the left ventricle by 47%, significantly less than the 85% increase in left ventricular weight. Because of this overestimation of myocyte hypertrophy based on ventricular weight measurements, the reduction in muscle mass-to-chamber volume ratio has to be considered to be markedly greater than that previously claimed. Because chamber volume expanded 4.6-fold and the myocyte compartment 1.5-fold, a 3.1-fold deficit in muscle mass was present for a complete restoration of ventricular mass-to-chamber volume ratio in the cardiomyopathic heart. This observation was restricted to the left ventricle because the expansions in myocyte and ventricular mass were similar in the right ventricle.
The phenomenon of ischemic myocyte death, segmental and diffuse, results not only in reparative processes associated with healing and scar formation but also in a reactive hypertrophic response of the overloaded remaining cells.6-9 Such a condition consistently has been found in the failing heart of both humans26,30,37-39 and animal models. 
